Region / East Asia
Materia medica, institutions and the stateThis directory connects materia medica, pharmaceutical investigation, state research, clinical testing, infectious-disease control, and the global movement of therapies across China, Korea, Japan, and wider networks.
People and research
The history resists a simple opposition between tradition and modern science: investigation moved through old recipes, extraction methods, state priorities, and collaborative testing.
Drugs and evidence
Materia medica depended on identification, harvesting, recipes, trade, extraction, toxicity, trials, and arguments about what counted as evidence.
Institutions and populations
Universities, hospitals, laboratories, ministries, and international agencies changed training, research, prevention, and access across different political systems.
Wider pathways
East Asian medical histories connect to military mobilisation, industrial production, humanitarian intervention, and international arguments about evidence and access.
Reading the region
“East Asian medicine” is a useful route into the collection, but it does not describe one stable system. Practitioners in China, Japan, Korea, and neighbouring communities worked in different languages, institutions, markets, and political settings. Texts and substances crossed those boundaries, yet they were selected, renamed, reformulated, and taught differently wherever they arrived.
The links above are best read at several scales. A materia medica can be studied as a written classification, a record of practical recipes, a product of skilled printing, or evidence for the movement of plants and drugs. Modern pharmaceutical research adds further layers: laboratory extraction, chemical analysis, clinical comparison, industrial manufacture, and regulation all change what a remedy is and who can use it.
War, occupation, state-building, and international health programmes also shaped medical priorities. Their archives often preserve the decisions of officials and researchers more clearly than the experiences of patients, rural practitioners, factory workers, or local caregivers. Moving between biographies, source profiles, institutions, and thematic guides helps keep those unequal records visible. Chronology matters as well: apparent continuity can conceal substantial changes in language, practice, ownership, and authority.
Collection direction
The collection should grow beyond its current artemisinin pathway toward practitioners, patients, institutions, and sources from China, Japan, Korea, and their diasporas across several historical periods.
All regions